Loading...

IGMS IGM BIOSCIENCES INC Business Restructuring 8-K Filing

GM B

GMS

IGM BIOSCIENCES INC

(IGMS)

2025 8-K

Show Summary

Summary

Merger of Equals

Non-Compliance with Listing...

Divestment of Assets

Restructuring Update

Company Restructuring

Financial Results

Restructuring Announcement

Strategic Pivot

Financial Results

Collaboration Revenue Update

Annual Meeting and Voting R...

Earnings Reports

Press Release Update

Financial Results Announcement

Financial Results

Strategic Refocusing

Earnings Reports

Management Changes

Earnings Reports

Annual Meeting Results

Public Offering and Common ...

Earnings Reports

Financial Results Announcement

Bylaws Amendment

Regulation FD Disclosure

Financial Update

External Links:

IGM Biosciences is restructuring by halting development of two bispecific antibody drugs and reducing its workforce by approximately 73% to conserve cash, with further cost details to be provided later.

AI Assistant

IGM BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.